A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

NCT05434585 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: ABO1009-DP
BIOLOGICAL: ABO-CoV.617.2
OTHER: Placebo

Sponsor

Suzhou Abogen Biosciences Co., Ltd.